07 jun: Bear Stearns, Ex-Executives, Agree to Settle Shareholder Suit for..
07 jun: ECB Foreign Exchange Reference Rates - Jun 07
07-06-2012 14:57:00

PRESS RELEASE: Bayer HealthCare Unveils Advances in CT Contrast Dose Management(TM) Solutions

Bayer HealthCare Unveils Advances in CT Contrast Dose Management(TM) Solutions

Powerful New Certegra(R) Informatics Workstation launched at SIIM 2012

Intended for U.S. Media Only

PR Newswire

TARRYTOWN, N.Y., June 7, 2012

TARRYTOWN, N.Y., June 7, 2012 /PRNewswire/ -- Bayer Radiology & Interventional announced the introduction of the Certegra(R) Workstation, an informatics-driven, touch--screen hub that enables time savings and improved patient care through a powerful suite of CT Contrast Dose Management(TM) applications and a new P3T(R) 2.0 operating environment. The new Workstation will be presented at the annual meeting of the Society for Imaging Informatics in Medicine (SIIM) 2012 June 7 - 12 in Orlando, FL. Following the initial launch in the U.S. and Canada, the Workstation will be rolled out in phases in markets around the world.

The Workstation serves as a single interface for radiology technologists, enabling them to provide improved patient care from study set-up and preparation to administration of the patient's study. It will be the cornerstone of Bayer's industry-first[1] Contrast Dose Management solution and informatics platform. In establishing and uploading the patient's contrast-injection record, the Workstation imports patient data directly from the Modality Work List -- reducing manual entry errors to the patient record.

"Today's technology-driven CT suite demands timely access to reliable contrast-dose records throughout the chain of care," said Anthony Cinalli, vice president of the informatics business at Bayer Radiology & Interventional. "Enabling a single workflow-centralized interface, the Workstation allows for fewer clicks, less manual entry and greater control over the quality and consistency of patient care."

Interfacing with Medrad Stellant(R) CT injection systems, the Workstation's comprehensive suite of software options provides physicians and healthcare professionals instant access to real-time actionable CT contrast data captured at the point of care enabling benefits including:

-- Reduce sub-diagnostic studies, unnecessary rescans and associated

radiation exposure[2] [3],(P3T 2.0 for personalized CT abdominal, cardiac

and pulmonary angiography studies)

-- Enable more complete diagnostic decisions (PACS Outbound Interface)

-- Speed-up radiology report turnaround time and create greater study-volume

bandwidth (RIS and SR Outbound Interfaces)

-- Improve department performance by trending, reporting and analyzing

actionable data with pinpoint accuracy (Informatics Starter Package, and

the Data Analysis and Reporting Tool)

Bayer HealthCare will have the Certegra(R) Workstation on display at its booth at SIIM 2012 (booth #217 - 221).

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

[1] Reference on file.

[2] Presented at Society of Thoracic Radiology (2008) Poster Session; Christopher R. Deible, MD, PhD. Study supported by MEDRAD Inc.

[3] 510(k) FDA clearance number: K082905

SOURCE Bayer HealthCare

/CONTACT: Karen Sutherland, +1-973-487-2113, karen.sutherland@bayer.com or Alicia Cafardi, +1-724-940-8621, alicia.cafardi@bayer.com

/Web site: http://www.bayerhealthcare.com/

(END) Dow Jones Newswires

June 07, 2012 08:57 ET (12:57 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
18 okt
OMXC20
Data herunder er lavet på C20 Cap og C20 vægtet til at passe til C20 Cap i 2010 og 2011.   Siden den..
66
17 okt
VWS
Normal 0 21 false false false DA X-NONE X-NONE ..
28
22 okt
VWS
Pokerchamp - Per Vimmer er gulddrengen trænet hos Goldman Sachs, som har lært den superliberalistisk..
22
20 okt
VELO
Match, så har jeg set lidt på mine handler og depoter.   Må begynde med at konkludere, at mit handel..
17
20 okt
VELO
Tvivler på at du får ret. Aktieanalytikerne siger allerede før godkendelsen en KORTSIGTET kurs på 2..
17
22 okt
BAVA
Jeg tror ikke, at mange her i dette forum er i tvivl om, hvem der er et fjols... Du får det til at l..
14
21 okt
VWS
Hvis du var en ludo brik var du så ikke slået hjem nu ???
14
23 okt
VWS
Quantum Utility Generation er på den anden side af "Mountain Friends", og de kan nu fortsætte deres ..
11
23 okt
VWS
Jeg har kigget lidt på Vestas USA kunde First Wind, for at se hvordan det går med de 3 Wind Power pr..
11
23 okt
 
Nej, der er klart tale om en Hanging Penis formation. Ikke et godt tegn. Jeg køber først når vi har ..
11

Vestas-kunde i stor aftale om strømsalg

24-10-2014 11:22:56
Den amerikanske udvikler af vindmølleprojekter Geronimo, som er kunde hos Vestas, har indgået aftale om salg af 140 megawatt af den kapacitet på 210 megawatt, s..

Aktier/tendens: Rockwool og Össur kan få opmærksomhed

24-10-2014 08:41:48
Rockwool og Össur kan meget vel komme i bevægelse fra morgenstunden fredag, efter henholdsvis en fyring og en opjustering af forventningerne.For det underliggen..

NKT-rival opjusterer efter salgsfremgang

23-10-2014 16:35:46
Amerikanske Tennant, der konkurrer med danske NKT inden for produktion af rengøringsmaskiner, fik en omsætningsfremgang på 7,5 pct. til 202,6 mio. dollar i tred..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas-kunde i stor aftale om strømsalg
2
Europa/aktier: Nøgletal overstrålede blandede regnskaber
3
OW Bunker/Nordea: Hæver anbefaling til "køb"
4
Aktier/tendens: Rockwool og Össur kan få opmærksomhed
5
Skandaleramt Krak-ejer stiger efter stort underskud
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
24. oktober 2014 14:45:13
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20141024.3 - EUROWEB7 - 2014-10-24 14:45:13 - 2014-10-24 14:45:13 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x